Logo image of DOW

DOW INC (DOW) Stock Fundamental Analysis

NYSE:DOW - New York Stock Exchange, Inc. - US2605571031 - Common Stock - Currency: USD

26.48  -0.52 (-1.93%)

Premarket: 26.57 +0.09 (+0.34%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to DOW. DOW was compared to 85 industry peers in the Chemicals industry. Both the profitability and financial health of DOW have multiple concerns. While showing a medium growth rate, DOW is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

DOW had positive earnings in the past year.
DOW had a positive operating cash flow in the past year.
DOW had positive earnings in each of the past 5 years.
In the past 5 years DOW always reported a positive cash flow from operatings.
DOW Yearly Net Income VS EBIT VS OCF VS FCFDOW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B

1.2 Ratios

Looking at the Return On Assets, with a value of 0.49%, DOW is in line with its industry, outperforming 45.88% of the companies in the same industry.
The Return On Equity of DOW (1.67%) is comparable to the rest of the industry.
DOW's Return On Invested Capital of 2.21% is on the low side compared to the rest of the industry. DOW is outperformed by 69.41% of its industry peers.
DOW had an Average Return On Invested Capital over the past 3 years of 4.98%. This is in line with the industry average of 6.84%.
Industry RankSector Rank
ROA 0.49%
ROE 1.67%
ROIC 2.21%
ROA(3y)3.48%
ROA(5y)4.48%
ROE(3y)10.49%
ROE(5y)15.16%
ROIC(3y)4.98%
ROIC(5y)6.12%
DOW Yearly ROA, ROE, ROICDOW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

DOW has a Profit Margin (0.66%) which is in line with its industry peers.
In the last couple of years the Profit Margin of DOW has declined.
DOW has a Operating Margin of 3.25%. This is in the lower half of the industry: DOW underperforms 70.59% of its industry peers.
DOW's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 9.38%, DOW is doing worse than 83.53% of the companies in the same industry.
DOW's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.25%
PM (TTM) 0.66%
GM 9.38%
OM growth 3Y-32.39%
OM growth 5Y-11.56%
PM growth 3Y-39.18%
PM growth 5YN/A
GM growth 3Y-18.23%
GM growth 5Y-6.06%
DOW Yearly Profit, Operating, Gross MarginsDOW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DOW is destroying value.
DOW has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DOW has less shares outstanding
The debt/assets ratio for DOW is higher compared to a year ago.
DOW Yearly Shares OutstandingDOW Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
DOW Yearly Total Debt VS Total AssetsDOW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

Based on the Altman-Z score of 1.71, we must say that DOW is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of DOW (1.71) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.96 indicates that DOW is somewhat dependend on debt financing.
DOW has a Debt to Equity ratio of 0.96. This is in the lower half of the industry: DOW underperforms 65.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Altman-Z 1.71
ROIC/WACC0.26
WACC8.37%
DOW Yearly LT Debt VS Equity VS FCFDOW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

A Current Ratio of 1.54 indicates that DOW should not have too much problems paying its short term obligations.
The Current ratio of DOW (1.54) is worse than 64.71% of its industry peers.
DOW has a Quick Ratio of 1.54. This is a bad value and indicates that DOW is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.90, DOW is doing worse than 71.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 0.9
DOW Yearly Current Assets VS Current LiabilitesDOW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

DOW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -47.30%.
The earnings per share for DOW have been decreasing by -12.16% on average. This is quite bad
The Revenue has decreased by -2.08% in the past year.
Measured over the past years, DOW shows a small growth in Revenue. The Revenue has been growing by 0.01% on average per year.
EPS 1Y (TTM)-47.3%
EPS 3Y-42.47%
EPS 5Y-12.16%
EPS Q2Q%-96.43%
Revenue 1Y (TTM)-2.08%
Revenue growth 3Y-7.88%
Revenue growth 5Y0.01%
Sales Q2Q%-3.1%

3.2 Future

Based on estimates for the next years, DOW will show a very strong growth in Earnings Per Share. The EPS will grow by 22.45% on average per year.
The Revenue is expected to grow by 1.26% on average over the next years.
EPS Next Y-79.89%
EPS Next 2Y-13.66%
EPS Next 3Y5.32%
EPS Next 5Y22.45%
Revenue Next Year-2.87%
Revenue Next 2Y0.05%
Revenue Next 3Y1.12%
Revenue Next 5Y1.26%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DOW Yearly Revenue VS EstimatesDOW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
DOW Yearly EPS VS EstimatesDOW Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 22.63, which indicates a rather expensive current valuation of DOW.
DOW's Price/Earnings is on the same level as the industry average.
DOW's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.15.
Based on the Price/Forward Earnings ratio of 20.77, the valuation of DOW can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DOW is on the same level as its industry peers.
DOW's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.60.
Industry RankSector Rank
PE 22.63
Fwd PE 20.77
DOW Price Earnings VS Forward Price EarningsDOW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

71.76% of the companies in the same industry are more expensive than DOW, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.89
DOW Per share dataDOW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.66%
EPS Next 3Y5.32%

6

5. Dividend

5.1 Amount

DOW has a Yearly Dividend Yield of 10.31%, which is a nice return.
Compared to an average industry Dividend Yield of 3.69, DOW pays a better dividend. On top of this DOW pays more dividend than 95.29% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, DOW pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.31%

5.2 History

DOW has been paying a dividend for at least 10 years, so it has a reliable track record.
As DOW did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years5
DOW Yearly Dividends per shareDOW Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

700.00% of the earnings are spent on dividend by DOW. This is not a sustainable payout ratio.
DP700%
EPS Next 2Y-13.66%
EPS Next 3Y5.32%
DOW Yearly Income VS Free CF VS DividendDOW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B
DOW Dividend Payout.DOW Dividend Payout, showing the Payout Ratio.DOW Dividend Payout.PayoutRetained Earnings

DOW INC

NYSE:DOW (6/30/2025, 8:04:00 PM)

Premarket: 26.57 +0.09 (+0.34%)

26.48

-0.52 (-1.93%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-24 2025-04-24/bmo
Earnings (Next)07-24 2025-07-24/amc
Inst Owners67.9%
Inst Owner Change0.34%
Ins Owners0.14%
Ins Owner Change13.33%
Market Cap18.72B
Analysts65
Price Target38.29 (44.6%)
Short Float %4.75%
Short Ratio3.3
Dividend
Industry RankSector Rank
Dividend Yield 10.31%
Yearly Dividend2.8
Dividend Growth(5Y)N/A
DP700%
Div Incr Years0
Div Non Decr Years5
Ex-Date05-30 2025-05-30 (0.7)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)100.93%
Min EPS beat(2)-100%
Max EPS beat(2)301.86%
EPS beat(4)2
Avg EPS beat(4)49.47%
Min EPS beat(4)-100%
Max EPS beat(4)301.86%
EPS beat(8)6
Avg EPS beat(8)29.87%
EPS beat(12)9
Avg EPS beat(12)23.71%
EPS beat(16)13
Avg EPS beat(16)19.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-1.99%
Max Revenue beat(2)0.85%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-1.99%
Max Revenue beat(4)1.19%
Revenue beat(8)5
Avg Revenue beat(8)0.21%
Revenue beat(12)7
Avg Revenue beat(12)0.78%
Revenue beat(16)10
Avg Revenue beat(16)1.29%
PT rev (1m)0.23%
PT rev (3m)-18.3%
EPS NQ rev (1m)-296.69%
EPS NQ rev (3m)-101.05%
EPS NY rev (1m)-7.16%
EPS NY rev (3m)-82.32%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-4.66%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)-2.86%
Valuation
Industry RankSector Rank
PE 22.63
Fwd PE 20.77
P/S 0.44
P/FCF N/A
P/OCF 7.37
P/B 1.11
P/tB 2.87
EV/EBITDA 7.89
EPS(TTM)1.17
EY4.42%
EPS(NY)1.27
Fwd EY4.81%
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)3.59
OCFY13.58%
SpS60.31
BVpS23.75
TBVpS9.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.49%
ROE 1.67%
ROCE 2.95%
ROIC 2.21%
ROICexc 2.28%
ROICexgc 2.94%
OM 3.25%
PM (TTM) 0.66%
GM 9.38%
FCFM N/A
ROA(3y)3.48%
ROA(5y)4.48%
ROE(3y)10.49%
ROE(5y)15.16%
ROIC(3y)4.98%
ROIC(5y)6.12%
ROICexc(3y)5.34%
ROICexc(5y)6.58%
ROICexgc(3y)7.02%
ROICexgc(5y)8.73%
ROCE(3y)6.67%
ROCE(5y)8.19%
ROICexcg growth 3Y-37.36%
ROICexcg growth 5Y-11.15%
ROICexc growth 3Y-36.83%
ROICexc growth 5Y-10.38%
OM growth 3Y-32.39%
OM growth 5Y-11.56%
PM growth 3Y-39.18%
PM growth 5YN/A
GM growth 3Y-18.23%
GM growth 5Y-6.06%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Debt/EBITDA 3.76
Cap/Depr 100.8%
Cap/Sales 6.83%
Interest Coverage 250
Cash Conversion 59.48%
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 0.9
Altman-Z 1.71
F-Score5
WACC8.37%
ROIC/WACC0.26
Cap/Depr(3y)86.15%
Cap/Depr(5y)75.88%
Cap/Sales(3y)5.12%
Cap/Sales(5y)4.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.3%
EPS 3Y-42.47%
EPS 5Y-12.16%
EPS Q2Q%-96.43%
EPS Next Y-79.89%
EPS Next 2Y-13.66%
EPS Next 3Y5.32%
EPS Next 5Y22.45%
Revenue 1Y (TTM)-2.08%
Revenue growth 3Y-7.88%
Revenue growth 5Y0.01%
Sales Q2Q%-3.1%
Revenue Next Year-2.87%
Revenue Next 2Y0.05%
Revenue Next 3Y1.12%
Revenue Next 5Y1.26%
EBIT growth 1Y-35.66%
EBIT growth 3Y-37.72%
EBIT growth 5Y-11.56%
EBIT Next Year61.84%
EBIT Next 3Y31.76%
EBIT Next 5Y24.7%
FCF growth 1Y-108.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.34%
OCF growth 3Y-25.36%
OCF growth 5Y-13.25%